Skip to main content
. 2018 Feb 26;15(3):350–362. doi: 10.1111/iwj.12872

Figure 5.

Figure 5

(A). Group I: vehicle control (ointment base) (magnified wound contraction view of vehicle control treated excision wound model of Wistar albino rats on different days); (B) Group II: standard control (povidone iodine 5% w/w ointment) (magnified wound contraction view of standard control treated excision wound model of Wistar albino rats on different days); (C) Group III: Cb‐peptide ointment (low dose 0.5 mg/mL) (magnified wound contraction view of Cb‐peptide ointment (low dose 0.5 mg/mL)‐treated excision wound model of Wistar albino rats on different days); (D) Cb‐peptide ointment (high dose 1 mg/mL) (magnified wound contraction view of Cb‐peptide ointment (figh dose 1 mg/mL)‐treated excision wound model of Wistar albino rats on different days)